Clo-miR-14: A medicinally valued spice-derived miRNA with Therapeutic Implications in Rheumatoid Arthritis.

IF 3.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Ashish Sarkar, Mohd Saquib, Debolina Chakraborty, Sonia Mann, Swati Malik, Prachi Agnihotri, Lovely Joshi, Rajesh Malhotra, Sagarika Biswas
{"title":"Clo-miR-14: A medicinally valued spice-derived miRNA with Therapeutic Implications in Rheumatoid Arthritis.","authors":"Ashish Sarkar, Mohd Saquib, Debolina Chakraborty, Sonia Mann, Swati Malik, Prachi Agnihotri, Lovely Joshi, Rajesh Malhotra, Sagarika Biswas","doi":"10.1042/BSR20240311","DOIUrl":null,"url":null,"abstract":"<p><p>Plant microRNAs (miRNA) are regularly consumed orally along with diet, gaining attention for their RNA-based drug potential because of their ability to regulate mammalian gene expression specifically at the post-transcriptional level. Medicinally valued plants are well known for their anti-inflammatory property; however, the contribution of their miRNA in managing inflammation has been less studied. We investigated miRNA from four medicinally valued regularly consumed spices, and validated one of the most potential miRNA \"Clo-miR-14\" for its thermal stability, and absorption in the plasma samples of RA patient's by RT-PCR. In-vitro and in-vivo studies were performed to investigate the effect of Clo-miR-14 in ameliorating Rheumatoid Arthritis (RA) like symptoms. Our results suggest that \"Clo-miR-14,\" an exogenous miRNA present in Curcuma longa, absorbed through regular diet, has robust thermal stability at 100℃ in humans. It significantly reduced pro-inflammatory cytokines (TNF, IL-1β, IL-6) and RA-like symptoms, suggesting that plant-based miRNA could be a promising candidate as an RNA-based drug for RA pathogenesis.</p>","PeriodicalId":8926,"journal":{"name":"Bioscience Reports","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioscience Reports","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1042/BSR20240311","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Plant microRNAs (miRNA) are regularly consumed orally along with diet, gaining attention for their RNA-based drug potential because of their ability to regulate mammalian gene expression specifically at the post-transcriptional level. Medicinally valued plants are well known for their anti-inflammatory property; however, the contribution of their miRNA in managing inflammation has been less studied. We investigated miRNA from four medicinally valued regularly consumed spices, and validated one of the most potential miRNA "Clo-miR-14" for its thermal stability, and absorption in the plasma samples of RA patient's by RT-PCR. In-vitro and in-vivo studies were performed to investigate the effect of Clo-miR-14 in ameliorating Rheumatoid Arthritis (RA) like symptoms. Our results suggest that "Clo-miR-14," an exogenous miRNA present in Curcuma longa, absorbed through regular diet, has robust thermal stability at 100℃ in humans. It significantly reduced pro-inflammatory cytokines (TNF, IL-1β, IL-6) and RA-like symptoms, suggesting that plant-based miRNA could be a promising candidate as an RNA-based drug for RA pathogenesis.

Clo-miR-14:一种具有药用价值的香料提取 miRNA,对类风湿性关节炎具有治疗意义。
植物微核糖核酸(miRNA)经常与饮食一起口服,由于它们能够在转录后水平调节哺乳动物基因的表达,因此其基于核糖核酸的药物潜力备受关注。有药用价值的植物以其抗炎特性而闻名,但对其 miRNA 在控制炎症方面的贡献研究较少。我们研究了四种经常食用的药用香料中的 miRNA,并通过 RT-PCR 验证了最有潜力的 miRNA 之一 "Clo-miR-14 "的热稳定性以及在 RA 患者血浆样本中的吸收情况。为了研究 Clo-miR-14 在改善类风湿关节炎(RA)症状方面的作用,我们进行了体外和体内研究。我们的研究结果表明,"Clo-miR-14 "是一种存在于莪术中的外源性 miRNA,可通过正常饮食吸收,在 100℃的温度下对人体具有很强的热稳定性。它能明显降低促炎细胞因子(TNF、IL-1β、IL-6)和类 RA 症状,这表明以植物为基础的 miRNA 有可能成为一种治疗类 RA 发病机制的 RNA 药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioscience Reports
Bioscience Reports 生物-细胞生物学
CiteScore
8.50
自引率
0.00%
发文量
380
审稿时长
6-12 weeks
期刊介绍: Bioscience Reports provides a home for sound scientific research in all areas of cell biology and molecular life sciences. Since 2012, Bioscience Reports has been fully Open Access and publishes all papers under the liberal CC BY licence, giving the life science community quality research to share and discuss.Content before 2012 is subscription-only, and is accessible via archive purchase. Articles are assessed on soundness, providing a home for valid findings and data. We welcome papers that span disciplines (e.g. chemistry, medicine), including papers describing: -new methodologies -tools and reagents to probe biological questions -mechanistic details -disease mechanisms -metabolic processes and their regulation -structure and function -bioenergetics
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信